Apidra 100 Units/ml, solution for injection in a cartridge
Last Updated on eMC 05-Jul-2017 View document | SANOFI Contact details
Versions
- 05-Jul-2017 to Current
- 30-Jun-2017 to 05-Jul-2017
- 23-Jan-2017 to 30-Jun-2017
- 02-Oct-2014 to 23-Jan-2017
- 01-May-2014 to 02-Oct-2014
- 23-Apr-2013 to 01-May-2014
- 16-Aug-2012 to 23-Apr-2013
- 04-May-2011 to 16-Aug-2012
- 23-Dec-2009 to 04-May-2011
- 05-Jan-2009 to 23-Dec-2009
- 29-Apr-2008 to 05-Jan-2009
- 18-Jun-2007 to 29-Apr-2008
- 11-Jul-2006 to 18-Jun-2007
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 05-Jul-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
- Change to section 3 - how to take/use
Updated on 30-Jun-2017 and displayed until 05-Jul-2017
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
Updated on 23-Jan-2017 and displayed until 30-Jun-2017
Reasons for adding or updating:
- Change to section 6 - marketing authorisation holder
Updated on 02-Oct-2014 and displayed until 23-Jan-2017
Reasons for adding or updating:
- Change to other sources of information section
Updated on 01-May-2014 and displayed until 02-Oct-2014
Reasons for adding or updating:
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
- Change to other sources of information section
Updated on 23-Apr-2013 and displayed until 01-May-2014
Reasons for adding or updating:
- Change to section 2 - pregnancy, breast feeding and fertility
Updated on 16-Aug-2012 and displayed until 23-Apr-2013
Reasons for adding or updating:
- Updates to formatting
Updated on 04-May-2011 and displayed until 16-Aug-2012
Reasons for adding or updating:
- Change to warnings or special precautions for use
Updated on 23-Dec-2009 and displayed until 04-May-2011
Reasons for adding or updating:
- Change due to harmonisation of PIL.
Updated on 05-Jan-2009 and displayed until 23-Dec-2009
Reasons for adding or updating:
- Changes to therapeutic indications
Updated on 29-Apr-2008 and displayed until 05-Jan-2009
Reasons for adding or updating:
- Transfer to upgraded management system
Updated on 18-Jun-2007 and displayed until 29-Apr-2008
Reasons for adding or updating:
- Change to date of revision
Updated on 11-Jul-2006 and displayed until 18-Jun-2007
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
SANOFI
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
+44 (0)1483 535 432
+44 (0)1483 505 515
+44 (0)845 372 7101
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue